|
|
|
|
|
1.
|
Coffee consumption modifies risk of estrogen-receptor negative breast cancer
Jingmei Li, Petra Seibold, Jenny Chang-Claude, Dieter Flesch-Janys, Jianjun Liu, Kamila Czene, Keith Humphreys, Per Hall Breast Cancer Research 2011, 13:R49 (14 May 2011)
Abstract | Full text | PDF | PubMed | F1000 Biology
|
Editor’s summary
A Swedish study finds that a high daily intake of coffee is associated with a statistically significant decrease in estrogen receptor-negative breast cancer among postmenopausal women.
|
|
|
2.
|
Stress and breast cancer: from epidemiology to molecular biology
Lilia Antonova, Kristan Aronson, Christopher R Mueller Breast Cancer Research 2011, 13:208 (21 April 2011)
Abstract | Full text | PDF | PubMed
|
|
|
3.
|
Breast cancer risk-assessment models
D Gareth R Evans, Anthony Howell Breast Cancer Research 2007, 9:213 (12 September 2007)
Abstract | Full text | PDF | PubMed
|
|
|
4.
|
Underarm antiperspirants/deodorants and breast cancer
Philippa D Darbre Breast Cancer Research 2009, 11(Suppl 3):S5 (18 December 2009)
Full text | PDF | PubMed |
|
|
|
5.
|
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
Grazia Arpino, Valerie J Bardou, Gary M Clark, Richard M Elledge Breast Cancer Res 2004, 6:R149-R156 (17 February 2004)
Abstract | Full text | PDF | Cited on BioMed Central
|
|
|
6.
|
Vitamin D and breast cancer: interpreting current evidence
Rowan T Chlebowski Breast Cancer Research 2011, 13:217 (16 August 2011)
Abstract | Full text | PDF | PubMed
|
|
|
7.
|
Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors
Helen J Hathaway, Kimberly S Butler, Natalie L Adolphi, Debbie M Lovato, Robert Belfon, Danielle Fegan, Todd C Monson, Jason E Trujillo, Trace E Tessier, Howard C Bryant, Dale L Huber, Richard S Larson, Edward R Flynn Breast Cancer Research 2011, 13:R108 (3 November 2011)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Antibody-conjugated magnetic nanoparticles and superconducting quantum interference device sensors may provide a useful, viable and highly-sensitive alternative to mammographic screening in breast tumor cell detection.
|
|
|
8.
|
Breast cancer stem cells: implications for therapy of breast cancer
Brian J Morrison, Chris W Schmidt, Sunil R Lakhani, Brent A Reynolds, J Alejandro Lopez Breast Cancer Research 2008, 10:210 (22 July 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
9.
|
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Joanne Kotsopoulos, Jan Lubinski, Leonardo Salmena, Henry T Lynch, Charmaine Kim-Sing, William D Foulkes, Parviz Ghadirian, Susan L Neuhausen, Rochelle Demsky, Nadine Tung, Peter Ainsworth, Leigha Senter, Andrea Eisen, Charis Eng, Christian Singer, Ophira Ginsburg, Joanne Blum, Tomasz Huzarski, Aletta Poll, Ping Sun, Steven A Narod, the Hereditary Breast Cancer Clinical Study Group Breast Cancer Research 2012, 14:R42 (9 March 2012)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Breastfeeding is protective against BRCA1- but not BRCA2-associated breast cancer, suggesting they have different biological pathways for carcinogenesis, and mutation carriers should be advised of the potential benefit of breastfeeding.
|
|
|
10.
|
Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study
Kristine H Allin, Børge G Nordestgaard, Henrik Flyger, Stig E Bojesen Breast Cancer Research 2011, 13:R55 (3 June 2011)
Abstract | Full text | PDF | PubMed
|
Editor’s summary
Elevated pre-treatment levels of plasma C-reactive protein (CRP) are predictive of poorer prognosis and increased death rates in breast cancer patients regardless of menopause, lifestyle factors and cardiovascular disease.
|
|
|
11.
|
Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis
Bhumsuk Keam, Seock-Ah Im, Kyung-Hun Lee, Sae-Won Han, Do-Youn Oh, Jee Kim, Se-Hoon Lee, Wonshik Han, Dong-Wan Kim, Tae-You Kim, In Park, Dong-Young Noh, Dae Heo, Yung-Jue Bang Breast Cancer Research 2011, 13:R22 (2 March 2011)
Abstract | Full text | PDF | PubMed
|
|
|
12.
|
The microenvironment in breast cancer progression: biology and implications for treatment
Andrew E Place, Sung Jin Huh, Kornelia Polyak Breast Cancer Research 2011, 13:227 (1 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
13.
|
The p53 pathway in breast cancer
Milena Gasco, Shukri Shami, Tim Crook Breast Cancer Res 2002, 4:70-76 (12 February 2002)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
14.
|
Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
Meredith M Regan, Karen N Price, Anita Giobbie-Hurder, Beat Thürlimann, Richard D Gelber, for the International Breast Cancer Study Group and BIG 1-98 Collaborative Group Breast Cancer Research 2011, 13:209 (26 May 2011)
Abstract | Full text | PDF | PubMed
|
|
|
15.
|
The role and function of cadherins in the mammary gland
Jennifer L Andrews, Alvin C Kim, Julie R Hens Breast Cancer Research 2011, 14:203 (8 February 2012)
Abstract | Full text | PDF
|
|
|
16.
|
Long-term prognosis of breast cancer detected by mammography screening or other methods
Tiina Lehtimäki, Mikael Lundin, Nina Linder, Harri Sihto, Kaija Holli, Taina Turpeenniemi-Hujanen, Vesa Kataja, Jorma Isola, Heikki Joensuu, Johan Lundin Breast Cancer Research 2011, 13:R134 (28 December 2011)
Abstract | Full text | PDF | PubMed |
|
Editor’s summary
Patients with breast cancer detected in mammography screening have a more favorable prognosis than those diagnosed outside a screening program and this should be taken into account in order to avoid over-treatment of screen-detected patients.
|
|
|
17.
|
Balancing harms and benefits of service mammography screening programs: a cohort study
Donella Puliti, Guido Miccinesi, Marco Zappa, Gianfranco Manneschi, Emanuele Crocetti, Eugenio Paci Breast Cancer Research 2012, 14:R9 (9 January 2012)
Abstract | Full text | PDF | PubMed | F1000 Medicine | F1000 Biology
|
|
|
18.
|
Epigenetics in breast cancer: what's new?
Yi Huang, Shweta Nayak, Rachel Jankowitz, Nancy E Davidson, Steffi Oesterreich Breast Cancer Research 2011, 13:225 (1 November 2011)
Abstract | Full text | PDF | PubMed
|
|
|
19.
|
Minimal residual disease and circulating tumor cells in breast cancer
Michail Ignatiadis, Monica Reinholz Breast Cancer Research 2011, 13:222 (25 October 2011)
Abstract | Full text | PDF | PubMed
|
|
|
20.
|
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M Fillmore, Charlotte Kuperwasser Breast Cancer Research 2008, 10:R25 (26 March 2008)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
21.
|
Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study
Alina Vrieling, Rebecca Hein, Sascha Abbas, Andreas Schneeweiss, Dieter Flesch-Janys, Jenny Chang-Claude Breast Cancer Research 2011, 13:R74 (26 July 2011)
Abstract | Full text | PDF | PubMed
|
|
|
22.
|
Anti-tumour activity of bisphosphonates in preclinical models of breast cancer
Ingunn Holen, Robert E Coleman Breast Cancer Research 2010, 12:214 (16 December 2010)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
23.
|
The ethics of CYP2D6 testing for patients considering tamoxifen
Anne-Renee Hartman, Paul Helft Breast Cancer Research 2007, 9:103 (13 April 2007)
Abstract | Full text | PDF | PubMed
|
|
|
24.
|
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction
Pierre-Emmanuel Colombo, Fernanda Milanezi, Britta Weigelt, Jorge S Reis-Filho Breast Cancer Research 2011, 13:212 (27 June 2011)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
In this review, the authors examine the clinical relevance of microarray-based profiling of breast cancer and discuss its impact on patient management.
|
|
|
25.
|
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells
Craig A Cooney, Fariba Jousheghany, Aiwei Yao-Borengasser, Bounleut Phanavanh, Tina Gomes, Ann Kieber-Emmons, Eric R Siegel, Larry J Suva, Soldano Ferrone, Thomas Kieber-Emmons, Behjatolah Monzavi-Karbassi Breast Cancer Research 2011, 13:R58 (9 June 2011)
Abstract | Full text | PDF | PubMed
|